Development of novel therapy with inhibition of Notch signaling for glioma stem cells
Project/Area Number |
15K19980
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Neurosurgery
|
Research Institution | Toho University |
Principal Investigator |
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Keywords | 神経膠腫 / グリオーマ幹細胞 / 神経膠芽腫 / Notch / 新規治療 / 分子標的治療 / γ-セクレターゼ阻害剤 / γセクレターゼ阻害薬 / 新規分子標的治療 |
Outline of Final Research Achievements |
The Notch signaling is an evolutionarily conserved pathway that plays an important role in multiple cellular processes. We investigated the effects of Notch inhibition in glioma stem cell (GSC) populations using γ secretase inhibitors. Drug cytotoxicity testing showed differential growth responses to the inhibitors. Responder GSCs had an enriched proneural gene signature in comparison to nonresponders. Analysis of TCGA dataset identified a group (43.9%) of tumors with proneural signature showing high Notch pathway activation. Inhibition of Notch pathway by γ secretase inhibitor treatment attenuated proliferation and self-renewal of responder GSCs and induces both neuronal and astrocytic differentiation. Our results suggest that proneural GBM characterized by high Notch pathway activation may exhibit greater sensitivity to γ secretase inhibitor treatment, holding a promise to improve the efficiency of current glioma therapy.
|
Report
(3 results)
Research Products
(11 results)
-
[Presentation] 神経膠芽腫におけるLMO2のSTAT3を介した細胞増殖機構の検討2016
Author(s)
齋藤紀彦, 青木和哉, 平井希, 藤田聡, 伊古田雅史, 岩間淳哉, 中山晴雄, 林盛人, 伊藤圭介, 櫻井貴敏, 岩渕聡
Organizer
第34回日本脳腫瘍学会学術集会
Place of Presentation
富士屋ホテル(山梨県甲府市)
Year and Date
2016-12-05
Related Report
-
[Presentation] Bevacizumab-induced normalization of tumor vasculature in glioblastoma2016
Author(s)
Saito N, Aoki K, Hirai N, Fujita S, Iwama J, Nakayama H, Hayashi M, Ito K, Sakurai T, Iwabuchi S
Organizer
21st Annual Meeting and Education Day of The Society for Neuro-Oncology(SNO2016)
Place of Presentation
Scottsdale, Arizona, USA
Year and Date
2016-11-19
Related Report
Int'l Joint Research
-
[Presentation] 神経膠芽腫におけるLMO2発現とその機能解析2016
Author(s)
齋藤紀彦, 青木和哉, 平井希, 藤田聡, 伊古田雅史, 岩間淳哉, 中山晴雄, 林盛人, 伊藤圭介, 櫻井貴敏, 岩渕聡
Organizer
日本脳神経外科学会第75回学術総会
Place of Presentation
福岡国際会議場(福岡県福岡市)
Year and Date
2016-09-29
Related Report
-
[Presentation] Levetiracetam downregulates O6-Methylguanine DNA methyltransferase expression and sensitizes temozolomide-resistant glioma cells2016
Author(s)
Saito N, Aoki K, Hirai N, Fujita S, Iwama J, Nakayama H, Hayashi M, Ito K, Sakurai T, Iwabuchi S
Organizer
3th Asian Society for Neuro-Oncology Meeting (ASNO)
Place of Presentation
Sydney, Australia
Year and Date
2016-09-12
Related Report
Int'l Joint Research
-
-
-
-
-
-
-